Drug shortage: Lisdexamfetamine Dimesylate Capsule (VYVANSE, LISDEXAMFETAMINE DIMESYLATE)
FDA lists 90 presentations as Current. Availability: Limited Availability (36), Available (54). Reason: Shortage of an active ingredient; Other. Companies: Takeda Pharmaceuticals USA Inc., Rhodes Pharmaceuticals L.P., Amneal Pharmaceuticals, Elite Laboratories, Inc., Apotex Corp.….
- Published by source
- 2023-07-14
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-23
Affected
- Manufacturer
- Takeda Pharmaceuticals USA Inc.
- Products
- Lisdexamfetamine Dimesylate Capsule VYVANSE LISDEXAMFETAMINE DIMESYLATE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Limited Availability
Remedy / actions:
- Estimated recovery: TBD
- On allocation
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2023-07-14
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #877 | new | 2026-10-22 | 632aca42e334…104cc6 | 42e90e067776…221d35 |
| #1155 | update | 2026-10-23 | f9276fc220db…7beacc | c051c383c036…d4ceb0 |
| #1349 | update | 2026-10-23 | 4b3be6ebca90…cb3080 | 50f8cc9b7ace…fdfc9c |
Chain head: #1479 ad3417dbc128…777bd4